RESOURCES TO EMPOWER YOUR GLP-1 JOURNEY WITH KNOWLEDGE AND INSPIRATION

A Jurni GLP phase where users actively implement new health strategies and monitor progress.

The body's ability to reduce energy expenditure during prolonged caloric restriction.

Fat tissue that stores energy and produces hormones.

Unintended or undesired side effects of a medication.

A once-weekly GLP-1 receptor agonist formerly sold for type 2 diabetes management.

The biological process of controlling food intake and hunger signals.

Drugs or supplements that reduce hunger and promote fullness.

The number of calories your body needs to perform basic functions at rest.

Cells in the pancreas responsible for producing insulin.

The rate and extent at which a drug or nutrient is absorbed and used by the body.

The force of blood against artery walls, important for heart health.

The concentration of glucose in the blood at any given time.

The ratio of fat to muscle in the body, crucial for overall health and fitness.

The percentage of total body weight composed of fat.

A measure of body fat based on height and weight.

A rapid-acting form of insulin taken around meals to manage blood sugar.

A type of fat that burns calories to generate heat, contributing to energy expenditure.

A once-weekly exenatide injection for diabetes control.

A twice-daily exenatide injection for diabetes management.

A marker of inflammation in the body, linked to chronic disease risk.

A state where calorie expenditure exceeds calorie intake, leading to weight loss.

The total amount of calories consumed through food and drink.

Consuming more calories than the body needs, leading to weight gain.

The health of the heart and blood vessels, often improved by weight loss.

The breakdown of complex molecules in living organisms to form simpler ones, releasing energy.

A Jurni GLP phase celebrating weight loss milestones and maintaining success.

A type of fat found in blood, essential but harmful in excess.

Long-term inflammation that can contribute to obesity, diabetes, and heart disease.

Research studies that evaluate the safety and effectiveness of medications or treatments.

The presence of multiple health conditions at the same time.

A device that continuously tracks glucose levels throughout the day.

Techniques and habits to reduce and manage cravings for unhealthy foods.

A Jurni GLP phase where users evaluate GLP-1 options and consider starting the medication.

Plant-based carbohydrates that aid digestion and satiety.

Proteins that break down food during digestion.

The gradual increase in medication dosage to minimize side effects and improve tolerance.

A medication that targets two receptors simultaneously, like GLP-1 and GIP, enhancing efficacy.

A GLP-1 receptor agonist used in Trulicity for type 2 diabetes management.

Abnormal levels of lipids in the blood, increasing cardiovascular risk.

Increased calorie burn after exercise as the body recovers.

The habit of eating in response to emotions rather than hunger.

The collection of glands that produce hormones regulating metabolism, growth, and reproduction.

A doctor specializing in hormone-related conditions.

The number of calories in a given weight of food.

The total energy used by the body in a day.

A GLP-1 receptor agonist sold under Byetta and Bydureon, used for diabetes treatment.

Glucose levels measured after fasting for a period of time.

The level of insulin in the blood after fasting, indicating insulin sensitivity.

The process by which the body breaks down fat for energy.

The redistribution of fat in the body, often seen during weight loss.

A common symptom of low energy or high glucose fluctuations.

A condition caused by excess fat in the liver.

A hormone that works alongside GLP-1 to stimulate insulin release and regulate blood sugar.

A class of medications that mimic the GLP-1 hormone to regulate blood sugar and promote weight loss.

A reduced response to GLP-1 medications over time, requiring higher doses or alternate strategies.

The series of organs responsible for digestion.

A hormone that stimulates hunger, often called the 'hunger hormone.'

A hormone that raises blood sugar levels when needed.

The ability to manage and stabilize blood glucose levels through diet, exercise, and medication.

A test that measures the body's response to glucose intake.

A form of stored carbohydrate in the liver and muscles, used as energy.

The collection of microorganisms living in the digestive system.

The communication between the gut and brain, influencing hunger and satiety.

A measure of average blood sugar levels over the past two to three months.

Fats that promote heart health, such as those in avocados and nuts.

A diet high in protein to promote muscle growth and satiety.

An imbalance in hormone levels affecting metabolism and weight.

Physical and psychological signals indicating hunger.

Higher than normal levels of insulin in the blood.

High blood pressure, often associated with obesity.

Low blood sugar, can cause dizziness and confusion.

A hormone that stimulates insulin release in response to food intake.

Areas of the body where GLP-1 injections can be administered safely and effectively.

A hormone that regulates blood sugar by facilitating glucose uptake.

The peak concentration of insulin in the bloodstream after eating.

A condition where cells do not respond properly to insulin.

The body's ability to effectively use insulin to lower blood glucose levels.

A measure of how much insulin is released in response to food intake.

A dietary pattern alternating between periods of eating and fasting.

The process by which the body produces ketones from fat for energy during low-carb states.

A low-carb, high-fat diet that promotes fat burning.

The portion of body weight that is not fat, including muscle, bone, and organs.

The amount of muscle in the body, essential for metabolism.

A hormone that regulates fat storage and satiety.

Changes to daily habits that promote health and weight loss.

A Jurni GLP phase in the GLP-1 journey focused on sustainable, healthy living habits.

The process by which the body handles fats, involving storage and breakdown.

A blood test measuring cholesterol and other fats in the blood.

A broader assessment of blood lipid levels, indicating cardiovascular health.

A GLP-1 receptor agonist used in Victoza and Saxenda to treat diabetes and aid in weight management.

Strategies to sustain weight loss and health improvements after discontinuing GLP-1 therapy.

Nutrients needed in large amounts: carbs, fats, proteins.

A weight loss program monitored by healthcare professionals.

The ability of the body to switch between using carbohydrates and fats for energy.

A cluster of conditions that increase risk of heart disease.

The chemical processes by which the body converts food into energy.

The collection of microorganisms that affect digestion and health.

A practice that encourages awareness and intention when eating, often improving satiety and digestion.

The health and efficiency of mitochondria, essential for energy production.

A tirzepatide-based injection used primarily for type 2 diabetes treatment and weight loss.

A condition where fat accumulates in the liver, unrelated to alcohol use.

The body's ability to absorb vitamins, minerals, and nutrients.

How the body directs nutrients to muscles or fat stores.

A condition characterized by excessive body fat.

A condition where body weight exceeds the healthy range.

Cellular damage caused by free radicals, contributing to aging and disease.

A semaglutide-based injection used to treat type 2 diabetes and promote weight loss.

An organ that produces insulin and other hormones to regulate blood sugar.

A protein that regulates various physiological functions, including appetite and insulin secretion.

The use of peptides to enhance various physiological processes, including fat loss.

Managing the amount of food consumed in one sitting.

Blood sugar levels measured after eating.

A condition where blood sugar is higher than normal but not diabetes.

The practice of consistently following prescribed medication routines.

Proteins involved in promoting inflammation, affecting weight and health.

An extended period without food intake, promoting fat burning and autophagy.

The process of building new proteins, vital for muscle growth.

A rapid reduction in body weight, often through extreme dieting or medical intervention.

Weight regained after stopping or reducing GLP-1 medication, often requiring lifestyle adjustments.

The number of heartbeats per minute while at rest, indicating cardiovascular fitness.

The number of calories burned while the body is at rest.

An oral version of semaglutide used to manage type 2 diabetes.

The loss of muscle mass, often occurring with aging or inactivity.

The feeling of fullness and reduced hunger after eating.

Hormones that promote feelings of fullness and reduce hunger.

A ranking of foods based on their ability to make you feel full.

A higher-dose liraglutide used for chronic weight management.

Tracking food, exercise, and weight to manage health.

A GLP-1 receptor agonist used in Ozempic and Wegovy to manage diabetes and support weight loss.

Muscles attached to bones, important for movement and metabolism.

A measure of subcutaneous fat using calipers at different body sites.

The tendency to eat in response to stress or emotional triggers.

Fat stored just beneath the skin, easier to lose compared to visceral fat.

The desire to consume sweet foods, often triggered by hormones.

The production of heat in the body, contributing to calorie burn.

Foods that stimulate the body's metabolic rate and increase calorie burn.

A dual GIP and GLP-1 receptor agonist found in Mounjaro, used for diabetes and obesity treatment.

The total number of calories burned daily, including exercise and bodily functions.

A type of fat in the blood that stores unused calories.

A dulaglutide injection used to treat type 2 diabetes.

A chronic condition that affects the body's ability to use insulin.

A measure of the maximum amount of oxygen the body can use during exercise.

The function of the vagus nerve in regulating digestion, heart rate, and mood.

A liraglutide-based injection for diabetes treatment.

The accumulation of fat around internal organs, associated with health risks.

Fat stored around internal organs, linked to health risks.

A measure comparing waist and hip circumference to assess health risks.

The accumulation of excess fluid in the body, causing temporary weight gain.

A higher-dose semaglutide injection specifically for chronic weight management.

The repeated loss and regain of body weight.

Strategies and behaviors to achieve and maintain a healthy weight.

A phase during weight loss when progress slows despite continued effort.

A type of fat that stores energy and cushions organs.

A type of fat that primarily stores energy and contributes to obesity.

Repeated cycles of dieting and weight regain.

A brand name for tirzepatide, designed for weight loss and diabetes control.